QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization

Abbott

Status: Completed

Conditions: Heart Failure

Treatments: Device: QuickOpt

Study type: Interventional

Funder types: Industry

Identifiers

NCT00918294

QuickOpt Study Asia

Details and patient eligibility

About

QuickOptTM optimization method provides a quicker, simpler and reliable alternative to standard echocardiography methods for optimization of sensed AV, paced AV and V-V delays in patients with CRT-P devices

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient meets current CRT-P indications and be implanted with an SJM CRT-P device with V-V timing and a compatible lead system
• Patient is able to provide written informed consent for study participation

Exclusion criteria

• Patient has limited intrinsic atrial activity (≤ 40 bpm)
• Patient has persistent or permanent AF
• Patient has a 2o or 3o heart block
• Patient is unable to provide analyzable echocardiogram images
• Patient's life expectancy is <12 months
• Patient is <18 years old
• Patient is pregnant
• Patient is on IV inotropic agents

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

QuickOpt

Experimental group

Description:

QuickOpt is an optimization algorithm to program the AV, PV and VV delays

Treatment:

Device: QuickOpt